WK3 - Heart Failure Flashcards

1
Q

Compare the difference in Tx for treating heart failure between 1972 and 2010.

A

1972 - “the earlier the bed rest is instituted after onset of cardiomyopathy, the greater the benefits expected”

2010 - “regular Ex is a safe and effective Tx modailty in most CHF patients, partially reversing some maladaptations in myocardial and skeletal muscle function = improves physical fitness and quality of life and perhaps reduced mortality”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Comment on the prevalence of heart failure in Aus.

A

2.1%/y - 511,000
- 67k new cases

158,000 admissions/y

61,000 HF deaths/y

3.1bil in healthcare/y

+146,000 / 10y
657,000 cases by 2025

  • the incidence on HF is increasing every year
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Comment on the prevalence of HF in QLD.

A

98k cases/y
- 12,600 new cases

30k admissions/y

11,900 HF-related deaths/y
- 1,700 deaths within 1y Dx

$600mil in healthcare /y
- 402mil in hospital care

+35,000 cases/10y
133,000 cases by 2025

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

1/3 - 2/3 HR admissions are preventable. T or F?

A

True
* Failure to adhere to prescribed therapy
– Pharmacological and non-pharmacological

  • Failure to recognise and seek early Tx for escalating
    Sx of CHF.
    – Poor discharge planning and follow up.
    – lack of social support, isolation, depression, cognitive impairment, multiple co-morbidities.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the typical trajectory of chronic heart failure?

A
  1. Dx
  2. responding to Tx
  3. clinical instability
  4. poor Tx response
  5. death
  • support and palliative care can bring patients back to stage 2
  • sudden death can occur after 1. between 2&3 and after 3.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Provide the pathophysiology of heart failure.

A
  • heart unable to pump at rate that is adequate for metabolising tissue (organs/muscles)
  • inability of LV to pump blood adequately can be due to failure of systolic or diastolic function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define chronic heart failure.

A
  • a complex clinical syndrome with typical signs and Sx (e.g. dyspnoea, fatigue) that can occur at rest or on effort.
  • secondary to an abnormality of cardiac structure/function that impairs ability of heart to fill with blood at normal pressure or eject blood sufficient to fulfill needs of metabolising organs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the causes of heart failure?

A
  • long-term hypertension
  • CAD
  • MI
    ^^ 60% of causes
    *chronic arrhythmias
  • valve problems
  • long term alcohol/drug issues
  • heart abnormalities present at birth
  • drug SE e.g. chemo
  • viral infections - HIV and flu
  • idiopathic - unknown causes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are secondary changes in the body that lead to heart failure?

A
  • degeneration/loss of cardiomyocytes
  • replacement with scarring and fibrosis
  • impaired myocardial contractility and valve competence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the hemodynamic changes that lead to heart failure?

A
  • decreased CO during Ex (or at rest)
  • elevated LV filling pressures
  • compensatory ventricular overload
  • elevated pulmonary and central venous pressures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the secondary organ changes that lead to heart failure?

A
  • major derangement in skeletal muscle metabolism
  • impaired vasodilation
  • renal insufficiency leading to Na+ and water retention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the difference between systolic and diastolic heart failure?

A

Systolic - HR with reduced EF (HRrEF)
* inability of cardiac myofibrils to contract/shorten against load, leading to reduce EF
* loss of muscle, usually due to MI
* loss of contractility

DIASTOLIC = HR with preserved EF (HRPEF)
* abnormal increase in resistance to filling LV
* stiff or non compliant chamber that is partially unable to expand as blood flows during diastole
* increased ventricular pressure, higher than noral filling pressures

SV for both sit below normal at 50mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does the heart compensate to maintain function?

A
  1. increase HR - maintain CO with reduced SV
  2. increase blood volume - use hormones and nerve signals to reduce blood flow to kidneys = retain Na+ to increase water retention
  3. cardiac remodelling - hypertrophy/chamber enlargement to cope with extra workload
    –> heart = stretched, less contractile = decreases efficiency of contraction = reduced amount of blood circulation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the heart’s compensatory mechanisms?

A
  • autonomic nerves - increased sympathetic adrenergic activity
  • hormonal - renin-angiotensin-aldosterone system
  • ventricular remodelling - dialtion and hypertrophy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the SNS response?

A
  • most immediate
  • stimualte beta-adrenergic receptors to elevate HR and increase contractility to augment SV = greater CO
  • epinephrine and norepinephrine = increased HR, contractility, vasoconstriction to increase CO

However also causes…
* increased preload, afterload, ventricular remodelling, hypertrophy, myocardial necrosis
* all advance HF overtime
* may trigger arrhythmias and sudden death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is triggered/activated by a decrease in Q, systemic BP and kidney perfusion?

A
  • caused by myocardial dysfunction - ischaemic heart disease, MI, valve disease, HTN, arrhythmias etc
  • activates baroreceptors (LV, carotid artery and aortic arch)
    –> vasomotor regulatory centres in medulla stimulated = SNS activated
    –> increase catecholamines (adrenaline) = vasoconstriction to increase afterload, BP and HR for ventricular remodelling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the RAAS system?

A

renin-angiotensin-aldosterone system
* regulation BP and water balance
* triggered by initial drop in kidney perfusion = increase Na+ and water absorption
= increased preload, afterload and contractility via
* increase blood volume, systemic filling pressure and venous return

  1. blood volume low = kidney secrete renin
  2. renin stimulates angiotensin I production -> converted to angiotensin II (powerful vasoconstrictor)
  3. angiotensin also stimulates secretion of hormone aldosterone from adrenal cortex = kidney tubules to retain Na+ and water = increased blood volume
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What causes ventricular remodelling?

A
  • abnormal pressure and volume overload = myocardial hypertrophy

Overtime may cause further impairment of pump performance due to…
* impaired systolic pump - impaired muscle function/collagen growth
* diastolic compliance changes - thickened ventricular walls

Hypertrophy alters cardiac function by depressant effect on ventricular compliance, rate and contraction force.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What does ventricular remodelling involve?

A
  • myocyte hypertrophy = large abnormal cells = cannot contract efficiently

eventually causes…
* increased LV mass
* changes in ventricular shape
* impaired contractility
* despite larger size, ventricle becomes less effective = increased chamber wall stress and O2 need

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What happens during ventricular dilation?

A

*ventricles dilate =spherical geometry
* Occurs as diastolic filling increases over time to augment contractility via increased preload (Frank-Starling Mechanism)
* LV dilation results in energetically unfavourable configuration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Explain heart failure progression.

A

Compensatory mechanisms:
* SNSactivation
* RAAS
* ventricular remodelling

Causes a shift to right of ventricular function curve, reflecting more pronounced increase in ventricular filling pressure with no further increase in cardiac performance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the Sx of HF?

A
  1. SOB
  2. feet/legs oedema
  3. weight gain or bloating
  4. tiredness
  5. appetite loss
  6. faintness or dizziness
  7. heart palpitations
  8. chest pain
  9. dry irritating cough
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the classifications of HF stages?

A

New York Heart Association (NYHA)

  • Class I – asymptomatic HF
    – No limitations to PA
  • Class II – mild HF; slight limitation of PA.
    – Ordinary PA =fatigue, palpitations, dyspnoea or angina
  • Class III – moderate HF;
    – Less than ordinary PA leads to Sx
  • Class IV – severe HF;
    – Sx at rest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Ex intolerance is the hallmark feature of HF. T or F?

A

True!
1. reduced pulmonary reserve
2. reduced cardiac reserve
3. skeletal muslce dysfunction
4. other factors: obesity, anaemia, unhealthy diet, peripheral vascular dysfunction, impaired autonomic regulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How is HF Dx?

A
  • chest x-ray - enlarged heart
  • echo - EF <50%
  • angiogram - CAD and LV function
  • blood test - brain natriuretic peptide >500 = likely HF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Explain the Dx testing.

A
  • based on signs and Sx
  • reduced EF
  • normal >50% HF/pEF
  • mod <40% HF/rEF
    -sev <30% sev HF/rEF
27
Q

Explain the Dx for HFpEF/diastolic HF.

A
  • somewhat less exact
  • echo can be used to evalate unique characteristics during diastole (i.e. L filling pressure)
  • Dx made when clinical syndrome of cnogestive HF (fatigue, dyspnoea, peripheral and pulmonary oedema) requires hospitalisation in presence of somewhat normal EF
28
Q

What is the medical Tx for CHF?

A

Relieve Sx:
* diuretics - fluid
* digoxin - regulate HR

Decrease disease progression/mortality:
* ACE inhibitors
* beta-blockers
* angiotensin receptor blockers
* spironolactone

29
Q

What are the meds used and explain their purpose?

A

Diuretics (“water pills”)
* reduce fluid heart has to pump e.g. Frusemide (Lasix)

ACE inhibitors or angiotensin II receptor 1 blockers - relax blood vessels and decrease BP ( PRILS or SARTANS)

Beta-blockers - relax blood vessels and/or slow heart down (LOLs)

Digoxin - slow pulse rate, help heart work more efficient

Vasodilators - hydralazine and isosorbide mononitrate, sometimes used to relax blood vessels

30
Q

What are some non-pharmacological management?

A

Fluid monitoring
* daily weight
* 4 W’s - wakeup, wee, weight, write

Fluid restriction
* 1.5-2L/day

Decrease salt intake
* 2300-2000mg/day
* 2000mg = 1 teaspoon

31
Q

How is HF self-managed?

A
  • adhere to meds
  • daily weight
  • restrict fluid intake
  • limit alcohol
  • limit salt
  • quit smoking
  • Ex
32
Q

What is cardiac resynchronisation therapy (CRT)?

A
  • CRT may be present in arrhythmia HF patients (i.e. where L and R chambers do not beat in unison)
    *CRT or biventricular pacing = help heart’s rhythm and arrhythmia Sx
  • procedure requires insertion of pacemaker - 3 wires (leads) connect to monitor HR and emit pulses of electricity to correct arrhythmia
33
Q

What are the benefits of CRT?

A
  • improve heart efficiency and blood flow
  • decrease HF Sx
  • clinical studies suggest decreased hospitalisation and morbidity and improved QoL
34
Q

What are the three types of permanent pacemakers?

A
  1. Single chamber - electrical signal sent to one heart chamber (usually ventricles)
  2. dual chamber - electrical signal sent to 2 heart chambers (usually top - atrium and bottom - ventricle)
  3. biventricular - electrical signal sent to 3 chambers. 2 sides of ventricles can be ent a signal to pump together – used to Tx HF
35
Q

What are implantable cardiac defibrillators (ICD)?

A

Small battery-powered device placed in chest

4 types:
1. single chamber
2. dual chamber
3. biventricular
4. subcutaneous - under skin at side of chest below armpit. Attached to electrode running along breastbone. AN S-ICD larger than traditional and doesnt attahc to heart

36
Q

Provide some thought on HF and Ex programs.

A
  • all patients with HF Sx should be offered Ex program
  • frailer and more symptomatic patients should not be excluded…
  • improved Ex capacity (peak VO2, 6MWT distance, submaximal endurance)
  • reduction in disease-specific Sx
  • improved QoL and reduced depressive Sx
  • reduced hospital admissions and improved survival
37
Q

What evidence is there of Ex and HF?

A
  • evidence shown all groups esp. NYHA Class 1-III
  • most research done with ischaemic causes of HF NYHA class I-III
  • Class IV may also benefit from Ex in form of home program/maintenance Ex
    *prior mid 1980s - Ex considered hazardous to people due to safety concerns - “further harm to weakened heart muscle”
  • numerous student in recent decade document safety and benefits from Ex
38
Q

What factor contribute to Ex intolerance?

A

Central:
* systolic function
* pulmonary hemodynamics
* diastolic dysfunction

Peripheral
* blood flow abnormalities
* vasodilatory capacity
* skeletal muscle
* biochemistry

Ventilatory
* pulmonary pressure
* ventilation-perfusion mismatch
* respiratory control
* breathing patterns

39
Q

What key factors limit Ex capacity?

A
  • decrease Q - underlies mismatch of ventilation to lung perfusion causing elevation in physiological dead space = increase SOB
  • SOBOE (SOB on exertion) = hallmark of CHF, roughly 2/3 limited by leg fatigue
  • lactate accumulates in blood at lower work rates - increase hyperventilation and early muscle fatigue
  • skeletal muscle abnormalities (decrease blood flow, distribution, vasodilatory capacity, abnormal muscle metabolism, mitochondrial enzyme activity
40
Q

What are the cardiac and cirulation benefits of Ex in HF?

A
  • SV
  • diastolic function
  • HR (at rest and submax work)
  • myocardial perfusion and arrhythmias
  • slowed SNS cascade nad ventricular remodelling
  • peripheral vasodilation/leg vascular resistance
  • blood distribution to Ex muscles
41
Q

What are the skeletal muscle benefits of Ex in HF?

A
  • mitochondrial no. and density
  • capillary density
  • muscle fibre size/bulk
  • circulating oxidative enzymes
  • delyaed lactate accumulation/onset of anaerobic metabolism

Improves O2 extraction, muscle strength and endurance

42
Q

What are the ventilation and “other” benefits of Ex in HF?

A

Ventilation:
* reduced ventilation at submax and max workloads
* dyspnoea and RPE/BORG
* O2 demands at submaximal workloads
* improved Sx and NYHA class

Other
* improve QoL scores and sleep quality
* weight bearing Ex and strength training maintains bone density
* reduced hospital admissions
* increased survival
* saving health costs

43
Q

What are some Ex consideratiosn for HF patients?

A
  • minimal or no changes in LVEF expected, even with Ex
  • evidence of reduced hospital admissions and improved 1y survival than those who Ex
  • no deaths rep in >100,000hrs Ex in research
44
Q

How do HF patients improve Ex capacity?

A

Based on the Fick Equation

VO2max = Q*AVO2diff

Q = HR*SV
AVO2diff = (CaO2-CvO2)

  • unique mechanism regulating arterio-venous O2 difference in sev HF patients (<30%)
  • activation contribute to efficient O2 delivery to peripheral tissues = compensating for jeopardised Ex tolerance in those patients
45
Q

What are some considerations of Ex training in HF patients?

A
  • Q is reduced at rest with Ex - limited ability to increase SV
  • reduced HR reserve (increase RHR and decrease HRmax)
  • Blood redistributed abnormally
  • peripheral vascular resistance is high
  • heightened ventilation - characteristic feature of Ex response
  • Ex can drop EF / SV or both
  • exertional hypotension may occur
46
Q

What services can AEPs provide to HF patients?

A
  • in-reach hospital - chart and patient review, discuss with med teams
  • case management/MDT approach
  • home visits, clinic appts, telehealth
  • titration clinic
    *education and monitoring - self management
  • work closely with GPs and cardiologists in community
  • multidisciplinary team involved
  • HF gym
  • palliative care for end stage HF
47
Q

What is included in the clinical Hx and Subjective Ax in HF patients?

A

Clinical Hx
* Dx
* past/current Sx
* relevant investgiations
* modifiable CV risks
* prescribed meds
* comobidities and pertinent med Hx
* family med Hx
* cognitive function

Ex specific:
* Ex habits past and present, lifestyle
* personal Ex preference
* barriers to Ex
* enablers to Ex
* social issues

Patient goals
* short term and long term

48
Q

What is included in the physical Ax in HF patients?

A
  • RHR and rhythm
  • BP – sitting and standing
  • BGL (if required)
  • O2 saturation
  • weight/Height (ask recent changes)
  • WC
  • fluid retention signs – orthopnoea, exertional
    dyspnoea, ankle oedema, bloating
  • Sternal stability, wound integrity and sensitivity in
    post surgical patients
  • Mobility status, safety with ambulation, falls risk
  • Further assessment (if required): balance,
    neurological factors, ROM
49
Q

What are the absolute and relative constraindications in HF patients for Ex?

A

Absolute:
* progressive worsening of Ex tolerance or dyspnoea at rest or on exertion over previous 3-5days

Relative:
* 2kg increase in body mass over previous 1-3days
* NYHA functional class IV

50
Q

What to consider in Ex testing in HF patients?

A
  • categorise HF severity (use NYHA)
  • cardiopulmonary testing - quantify Ex tolerance
  • measure CRF (VO2peak) / risk stratification
  • determine impairment degree and ventilatory abnormalities
    *Ex ECG offers little insight
  • graded Ex testing - Ax physiological responses to Ex, and est. maximal METs for risk stratification
  • Sx of decompensation = contraindicated
  • Sx frequently under 5METs
  • exertional hypotension, dysrhythmias may occur
  • test endpoints - focus on Sx, haemodynamic response nad standard clinical indications - NOT target HR

6MWT - useful
+ TUG
+ grip strength

51
Q

What is considered low risk?

A
  • LV EF >50%
  • no resting/Ex induced dysarrhythmias
  • normal haemodynamic/ECG repsonse
  • ASx with Ex, no angina
  • max. capcity >7.0METs
  • absence of depression
52
Q

What is considered intermediate risk?

A
  • LV EF = 40-50%
  • signs/Sx including anging at “moderate” levels of Ex (60-75% of max. capacity)
  • mild to mod silent ischaemia (ST depression <2mm) with Ex or Rx
53
Q

What is considered high risk?

A
  • LV EF <40%
  • survivor of MI
  • complex ventricular dysrhythmias
  • MI complicated by cardiogenic shock
  • abnormal haemodynamics with Ex
  • sig. silent ischaemia
  • signs/Sx including angina, dizziness
  • maximal capacity <5METs
  • clinically sig. depression
54
Q

What is the risk stratification for EF%?

A
  • American Heart Association Guidelines for Ex Testing and training - do not use EF% alone to Ax risk!
  • stable HF patients with EF <30% - low risk with vig Ex if NYHA Class 1 or 2 and other clinical characteristics are low risk
  • mod-high risk with vig Ex if NYHA class II or IV
55
Q

What are some self-management points to remind patients?

A
  • medicines intake
  • weight themselves daily
  • fluid and sodium restrictions
  • limits alcohol and tobacco
  • HF action plan?
56
Q

What is the aim of cardiac rehab program?

A
  • help people with CVD return to an active and satisfying life, to prevent recurrence of cardiac events

Broad aims:
* max. physical, psych and social functioning - to live a fulfilling life
* introduce behaviour that can minimise risk of further cardiac events

57
Q

What are the phases of cardiac rehab?

A
  1. inpatient - in reach - Rx
  2. outpatient
  3. maintenance
58
Q

What are the indications for outpatient CR?

A
  • medicall stable postmyocardial infarction
  • stable angina
  • CABG
  • percutaneous transluminal coronary angioplasty
  • stable HF caused by systolic or diastolic dysfunction
  • heart transplantation
  • valvular heart disease
  • peripheral arterial disease
  • at risk for CAD
    *other patients who may benefit from Ex
  • atrial fibrillation, congenital heart disease, pulmonary hypertension
59
Q

What are the contraindications for outpatient CR?

A
  • unstable angina
  • uncontroll HTN
  • orthostatic BP
  • sig/ aortic stenosis
  • uncontraolled atrial/ventricular arrhythmias/tachys
  • uncompensated HF
  • 3rd degree AV block without pacemaker
  • active pericarditis/myocarditis
  • recent embolism
  • acute thrombophlebitis
  • aortic dissection
  • acute systemic illness or fever
  • uncontrolled diabetes
    *sev orthpedic that would prohibit Ex
    *other conditions
  • sev psych disorder
60
Q

Whst are some goals?

A
  • develop/assist patient to implement safe and effective formal Ex and lifestyle PA
  • supervise/monitor to detect changes
  • ongoing surveillance to patients healthcare providers to enhance med management
    *return patient to vocational/recreational activities or be modified
    *provide patient and spouse/parter/fam education to optimise 2ndary prevention
61
Q

What are the typical characteristics of CR?

A

Personnel
* EP/physio
* cardiac nurse
* dietitian, psych, social worker, OT
* med director

Format
* group-based Ex class
* group-based education
* 1:1 initial and discharge Ax

62
Q

What is part of the pre-session monitoring routine?

A

During:
* change in clinical status
* BP, HR, O2 saturation, BGL
* for HF, bodyweight (>2kg in 48hr)
* signs/Sx of reduced Ex tolerance

During maintenance phase
* teach self-monitoring
* begin weaning off monitoring to minimise dependency

63
Q

What are the red flags for worsening HF?

A
  • > 1.8kg increase over 48hrs
  • worsening dyspnoea
  • excessive fatigue
  • swelling legs/abdomen
  • productive cough
  • increased urination (particularly at night - nocturia)
  • difficulty sleeping due to breathing problems (orthopnoea)
  • difficulty concentrating
  • shock from an implantable cardiac defibrillator